In the last trading session, 365.05 million shares of the Syros Pharmaceuticals Inc (NASDAQ:SYRS) were traded, and its beta was 1.47. Most recently the company’s share price was $0.28, and it changed around $0.08 or 39.24% from the last close, which brings the market valuation of the company to $7.42M. SYRS currently trades at a discount to its 52-week high of $8.17, offering almost -2817.86% off that amount. The share price’s 52-week low was $0.18, which indicates that the current value has risen by an impressive 35.71% since then. We note from Syros Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 8.83 million shares, with the 3-month average coming to 1.65 million.
Syros Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 4 recommended SYRS as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Syros Pharmaceuticals Inc (NASDAQ:SYRS) trade information
Instantly SYRS has showed a green trend with a performance of 39.24% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4096 on recent trading dayincreased the stock’s daily price by 31.64%. The company’s shares are currently down -96.45% year-to-date, but still down -89.86% over the last five days. On the other hand, Syros Pharmaceuticals Inc (NASDAQ:SYRS) is -87.64% down in the 30-day period. We can see from the shorts that 1.25 million shares have been sold at a short interest cover period of 3.2 day(s).
The consensus price target as assigned by Wall Street analysts is $15, which translates to bulls needing to increase their stock price by 98.13% from its current value. Analyst projections state that SYRS is forecast to be at a low of $5 and a high of $30.
Syros Pharmaceuticals Inc (SYRS) estimates and forecasts
Syros Pharmaceuticals Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -95.10 percent over the past six months and at a 65.53% annual growth rate that is well above the industry average of 17.80%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 21.16%.
SYRS Dividends
Syros Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in December.
Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.34% of Syros Pharmaceuticals Inc shares, and 75.52% of them are in the hands of institutional investors. The stock currently has a share float of 77.33%.
